Analysts who follow Lumos Pharma Inc (LUMO) on average expect it to rise 26.94% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns the stock an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Lumos Pharma Inc Stock Today?
Lumos Pharma Inc (LUMO) stock is trading at $14.18 as of 12:34 PM on Tuesday, Jul 28, a drop of -$0.64, or -4.29% from the previous closing price of $14.81. Volume today is more active than usual. So far 152,248 shares have traded compared to average volume of 30,650 shares. The stock has traded between $13.52 and $16.21 so far today.
